Literature DB >> 1587762

High dose endobronchial irradiation in recurrent bronchogenic carcinoma.

M Gauwitz1, N Ellerbroek, R Komaki, J B Putnam, M B Ryan, L DeCaro, M Davis, J Cundiff.   

Abstract

Between November 1988 and March 1990, 24 patients with endobronchial tumors that had recurred after external beam radiation therapy were treated with high dose rate intraluminal irradiation. A remote afterloading high dose rate unit was used, and most patients received two endobronchial treatments, separated by a two week interval. All patients were given the same dose and dose specification to assess the feasibility and complications of the therapy. At each treatment, 15 Gy were delivered with dose specified at a radius of 6 mm from the center of the source, which corresponds to a dose of 9 Gy at a radius of 1 cm. Overall, 21 of 24 patients (88%) showed good symptomatic improvement. Of 18 patients whose chest x-ray showed evidence of collapse or atelectasis caused by tumor obstruction, 15 (83%) had evidence of reaeration. The median duration of palliation, marked by symptoms or a chest x-ray that worsened, was 26 weeks, the range varying from seven to 40 weeks. No patient died as a result of therapy and only one had a complication, bronchospasm, which responded well to bronchodilators. One patient died of hemoptysis approximately three months after treatment. Five additional patients, who were treated off protocol because they had an Eastern Cooperative Oncology Group performance status of greater than two, also received endobronchial irradiation. All five died within one month from worsening pulmonary disease, and we do not recommend endobronchial irradiation for patients with an Eastern Cooperative Oncology Group performance status of greater than two. We conclude that high dose rate endobronchial brachytherapy effectively relieves the symptoms of endobronchial obstruction due to recurrent lung cancer and can be given safely as an outpatient procedure. As the complications were minimal in this series treated with a uniform dose of 15 Gy per treatment, future studies should aim at determining the maximum tolerated dose. This technique may also be helpful as a boost after maximal external beam irradiation or to open up areas of atelectasis prior to external beam irradiation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1587762     DOI: 10.1016/0360-3016(92)90759-b

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  6 in total

1.  Lung Cancer: A Bronchoscopic Approach.

Authors:  János Strausz
Journal:  Pathol Oncol Res       Date:  1996       Impact factor: 3.201

Review 2.  Brachytherapy in the treatment of lung cancer - a valuable solution.

Authors:  Janusz Skowronek
Journal:  J Contemp Brachytherapy       Date:  2015-09-14

3.  Mature results of a randomized trial comparing two fractionation schedules of high dose rate endoluminal brachytherapy for the treatment of endobronchial tumors.

Authors:  Olivier M Niemoeller; Barbara Pöllinger; Maximilian Niyazi; Stefanie Corradini; Farkhad Manapov; Claus Belka; Rudolf M Huber
Journal:  Radiat Oncol       Date:  2013-01-07       Impact factor: 3.481

4.  Second line palliative endobronchial radiotherapy with HDR Ir 192 in recurrent lung carcinoma.

Authors:  A Faruk Zorlu; Ugur Selek; Salih Emri; Murat Gurkaynak; Fadil H Akyol
Journal:  Yonsei Med J       Date:  2008-08-30       Impact factor: 2.759

5.  Dose reconstruction technique using non-rigid registration to evaluate spatial correspondence between high-dose region and late radiation toxicity: a case of tracheobronchial stenosis after external beam radiotherapy combined with endotracheal brachytherapy for tracheal cancer.

Authors:  Kazuma Kobayashi; Naoya Murakami; Koji Inaba; Akihisa Wakita; Satoshi Nakamura; Hiroyuki Okamoto; Jun Sato; Rei Umezawa; Kana Takahashi; Hiroshi Igaki; Yoshinori Ito; Naoyuki Shigematsu; Jun Itami
Journal:  J Contemp Brachytherapy       Date:  2016-04-29

6.  Endobronchial brachytherapy with curative intent: the impact of reference points setting according to the bronchial diameter.

Authors:  Yoshihito Nomoto; Noriko Ii; Shuichi Murashima; Yasufumi Yamashita; Satoru Ochiai; Akinori Takada; Yutaka Toyomasu; Tomoko Kawamura; Hajime Sakuma
Journal:  J Radiat Res       Date:  2017-11-01       Impact factor: 2.724

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.